TickerFacts.

Annexon, Inc. (ANNX): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$2.17M
Year ended 2025-12-31
$2.17M
Trailing 12 months to 2026-06-30
+0.9%
3-year compound annual growth
+26.6%
5-year compound annual growth
2019-12-31: $493.0K2020-12-31: $667.0K2021-12-31: $2.14M2022-12-31: $2.11M2023-12-31: $2.15M2024-12-31: $2.15M2025-12-31: $2.17M$2.17M
2019-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$2.17M+0.7%2026-03-30, From 2025-01-01
2024-12-31$2.15M+0.1%2026-03-30, From 2024-01-01
2023-12-31$2.15M+2.0%2025-03-03, From 2023-01-01
2022-12-31$2.11M-1.6%2024-03-26, From 2022-01-01
2021-12-31$2.14M+221.0%2023-03-06, From 2021-01-01
2020-12-31$667.0K+35.3%2022-03-01, From 2020-01-01
2019-12-31$493.0Kn/a2021-03-25, From 2019-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Annexon, Inc. (ANNX)2025-12-31$2.17M+0.7%
Tonix Pharmaceuticals Holding Corp. (TNXP)2025-12-31$1.90M-34.5%
Contineum Therapeutics, Inc. (CTNM)2025-12-31$323.0K+25.2%
Nektar Therapeutics (NKTR)2025-12-31$1.03M-76.6%
Enanta Pharmaceuticals Inc (ENTA)2025-09-30$4.59M+96.3%
Tyra Biosciences, Inc. (TYRA)2025-12-31$546.0K+5.2%
Arcturus Therapeutics Holdings Inc. (ARCT)2025-12-31$3.02M-14.6%
Zevra Therapeutics, Inc. (ZVRA)2025-12-31$4.05M-36.5%
Perspective Therapeutics, Inc. (CATX)2025-12-31$3.25M+41.0%

Compare ANNX, TNXP, CTNM, NKTR side by side · Screen every company in Pharmaceutical Preparations ↗